Volpara Health Technologies Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand.
|Primary activities||Develops digital health solutions to enable personalised breast cancer screening software applications|
|Industry / Sector||Health Information Services / Healthcare|
|Full time employees||189|
|Mailing address||Simpl House Level 14 40 Mercer Street Wellington Central Wellington 6011 New Zealand|
|Phone / Fax||64 4 499 6029 / 64 4 499 6029|
|Share registry||BOARDROOM PTY LIMITED|
Volpara Health Technologies paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.VHT dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
VHT's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Oct 2022, following are the company executives and directors listed on Volpara Health Technologies.
|Dr. Ralph P. Highnam B.Sc., M.Sc., Ph.D.||Founder, MD, Chief Scientist & Chief Science and Innotion Officer||328.91k|
|Mr. Craig Hadfield||CFO & Company Sec.||196.52k|
|Ms. Teri Thomas||Chief Exec. Officer|
|Prof. Nico Karssemeijer||Co-Founder & Member of Scientific Board|
|Mr. Tana Isaac||Exec. VP of Product & Technology|
|Mr. Gareth Beaumont||Chief Information Officer & Chief Information Security Officer|
|Mr. Fred Struve B.Sc., J.D.||Gen. Counsel|
|Ms. Jill Spear||Exec. VP of Sales & Marketing|
|Ms. Kathryn Greene||Chief People Officer|
|Mr. Julian Marshall||Chief Knowledge Officer|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Volpara Health Technologies is and its enterprise value is .
The VHT's stocks Beta value is 1.07 making it 7% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Volpara Health Technologies (VHT)
- Ansell (ANN)
- Cochlear (COH)
- Fisher & Paykel Healthcare Corporation (FPH)
- Estia Health (EHE)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Resmed Inc (RMD)
- Ramsay Health Care (RHC)
- Polynovo (PNV)
- Sonic Healthcare (SHL)
Volpara Health Technologies (ASX:VHT) Frequently Asked Questions
1. What is Volpara Health Technologies's Stock Symbol?
Volpara Health Technologies trades on ASX under the ticker symbol "VHT".
2. What is Volpara Health Technologies's stock price today?
One share of VHT stock can currently be purchased for approximately $0.565.
3. How can I contact Volpara Health Technologies?
Volpara Health Technologies's mailing address is Simpl House Level 14 40 Mercer Street Wellington Central Wellington 6011 New Zealand. The company can be reached via phone at 64 4 499 6029.
4. What is Volpara Health Technologies's official website?
The official website of Volpara Health Technologies is https://www.volparahealth.com.
5. Which share registry manages Volpara Health Technologies's stock?
Volpara Health Technologies's stock is managed by BOARDROOM PTY LIMITED.